www.fdanews.com/articles/114067-geopharma-gets-2-5-million-for-cancer-business

GeoPharma Gets $2.5 Million for Cancer Business

January 26, 2009

GeoPharma Inc. signed an agreement to sell a 60 percent stake in its ovarian cancer business to Trident Biotech Inc.
Tampa Bay Business Journal